Charles River Laboratories International, Inc.

CRL · NYSE
Analyze with AI
9/27/2025
6/28/2025
3/29/2025
12/31/2024
Assets
Cash & Equivalents$207,670$182,824$229,356$194,606
Short-Term Investments$0$0$0$0
Receivables$734,482$767,569$756,629$720,915
Inventory$302,550$279,550$290,156$278,544
Other Curr. Assets$7,913$129,921$100,230$105,796
Total Curr. Assets$1,532,104$1,469,862$1,506,358$1,403,071
Property Plant & Equip (Net)$1,965,898$1,992,489$1,989,977$2,016,504
Goodwill$2,922,281$2,936,265$2,873,402$2,846,608
Intangibles$571,094$602,452$655,705$723,400
Long-Term Investments$196,185$216,073$214,026$218,350
Tax Assets$36,907$46,943$48,794$42,179
Other NC Assets$289,343$296,461$294,104$278,233
Total NC Assets$5,981,708$6,090,683$6,076,008$6,125,274
Other Assets$0$0$0$0
Total Assets$7,513,812$7,560,545$7,582,366$7,528,345
Liabilities
Payables$169,615$145,798$149,334$140,337
Short-Term Debt$2,636$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$237,728$268,340$250,462$248,322
Other Curr. Liab.$386,844$434,733$408,792$373,432
Total Curr. Liab.$1,121,888$1,080,438$1,051,055$994,101
LT Debt$2,159,981$2,332,374$2,510,754$2,240,205
Deferred Rev, NC$42,492$0$0$0
Deferred Tax Liab, NC$123,007$109,273$107,268$106,960
Other NC Liab.$146,970$185,210$196,396$195,212
Total NC Liab.$2,941,107$3,080,521$3,289,529$3,026,166
Other Liabilities$0$0$0$0
Cap. Leases$0$453,664$475,111$483,789
Total Liabilities$4,062,995$4,160,959$4,340,584$4,020,267
Equity
Pref Stock$0$0$0$0
Common Stock$514$513$512$511
Retained Earnings$1,944,317$1,889,895$1,837,569$1,812,100
AOCI-$191,616-$166,467-$265,246-$317,345
Other Equity$0$0$0$0
Total Equity$3,405,449$3,353,321$3,194,336$3,461,503
Supplemental Information
Minority Interest$45,368$46,265$47,446$46,575
Total Liab. & Tot. Equity$7,513,812$7,560,545$7,582,366$7,528,345
Net Debt$1,954,947$2,149,550$2,281,398$2,045,599
Charles River Laboratories International, Inc. (CRL) Financial Statements & Key Stats | AlphaPilot